SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : La Jolla Diagnostics, Inc.(OTC BB: LAJD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Popiye who wrote (100)1/14/1999 11:20:00 AM
From: jeffrey rainey  Read Replies (1) of 168
 
LA JOLLA, CALIF. (Jan. 14) BW HEALTHWIRE -Jan. 14, 1999--La Jolla
Diagnostics Inc. (OTC BB:LAJD), announced today that its subsidiary
DiagnosTech Inc. has received confirmation that clinical trials on the
company's rapid diagnostic TB test have been successfully completed at
Beijing Children's Hospital.

This proprietary, patent pending rapid diagnostic test for active
tuberculosis is a unique breakthrough product for a disease which is a
major problem in many countries. The accuracy of this TB test has been
confirmed in three separate clinical trials, and it is currently being
sold in several countries with approvals pending in numerous others.
Presently there is no other test available that can rapidly determine
if the disease is an active state.

DiagnosTech's Hong Kong based distributor, Winnimax, plans to submit a
formal registration application for the product to the Chinese Ministry
of Health this coming March.

The World Health Organization (WHO) projects that a total of 1 billion
TB tests will be performed annually by the year 2000. Approximately 25
percent of active TB cases occur in China.

La Jolla Diagnostics is an emerging company engaged in the development
and marketing of state-of-the-art diagnostic tests, health care
products and nutraceuticals. The health care and nutraceuticals
products, including a treatment for migraine headaches, are formulated
using a patented technology.

-0- jm/sd* sf/sd

CONTACT: La Jolla Diagnostics Inc.
800/454-6790, Fax 619/454-7851

lajd.com
lajd96@aol.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News